Chris Brightling is the ERS Science Council Chair.
He is Professor of Respiratory Medicine at the University of Leicester, a Fellow of the Academy of Medical Sciences and Senior Investigator with the UK's National Institute for Health Research.
His work focuses on improving the clinical management and understanding the immunopathogenesis of airway diseases such as asthma, chronic cough and COPD.
My top pick would be the Abstracts Leading to Evolution in Respiratory Medicine Trials (ALERT) sessions. These sessions provide the most up-to-date cutting-edge research that impacts on clinical management, showcasing important and very late-breaking clinical trial data from all respiratory disease areas. With presenters, session chairs and viewers taking part in lively discussions on the presented trials, these sessions will really be something to look forward to.
The year in review of biologics in asthma will help us to understand where they best fit in asthma management and what are the remaining unmet needs. For COPD, the hot topic session exploring resetting ambition in COPD towards its elimination will allow discussion of new paradigms for COPD research.
1. I enjoy the lungs on fire sessions which always present clinical challenges.
2. The thematic poster sessions are fascinating, as they allow interaction and debate about current research.
3. Finally, with this being our first face-to-face Congress since 2019, I am looking forward to meeting and interacting with new and old colleagues.